Saturday, October 3, 2026

CBOE Jumps By 9% In The Last 24 Hours

ViaNews Editorial Team

February 10, 2023

CBOE Jumps By 9% In The Last 24 Hours

(VIANEWS) - CBOE (VIX) has been up by 9.22% for the last session's close. At 06:08 EST on Friday, 10 February, CBOE (VIX) is $21.44.

CBOE Range

About CBOE's daily highs and lows, it's 12.72% up from its trailing 24 hours low of $19.02 and 1.71% up from its trailing 24 hours high of $21.08.

Regarding CBOE's yearly highs and lows, it's 25.67% up from its 52-week low and 43.27% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a positive 3.81%, a negative 0.27%, and a positive 4.10%, respectively.

CBOE's highest amplitude of average volatility was 3.81% (last week), 4.71% (last month), and 4.10% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be oversold (<=20).

News about

  • According to FXStreet on Wednesday, 8 February, "Against this backdrop, S&P 500 Futures remain indecisive while Indian equities lick their wounds by the press time."
  • According to FXStreet on Wednesday, 8 February, "Amid these plays, S&P 500 Futures fail to track Wall Street's gains while stocks in the Asia-Pacific bloc remain indecisive as traders await US President Biden's State of the Union (SOTU) speech."
  • According to FXStreet on Wednesday, 8 February, "Even so, the S&P 500 Futures print mild losses near 4,170 while paring the biggest daily jump in nearly a week whereas the US 10-year Treasury bond yields snap a three-day uptrend while retreating from a one-month high of around 3.68% to 3.66% by the press time."
  • According to DailyForex on Wednesday, 8 February, "If we were to break down below the 4100 level, that is very likely that we see the S&P 500 trying to get back down to the 200-Day EMA and the downtrend line, which coincides with roughly 4000. "

More news about CBOE (VIX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com